(Q34746394)

4 August 2017

1 reference

title

The neuropharmacology of centrally-acting analgesic medications in fibromyalgia (English)

1 reference

4 August 2017

0 references

Srinivas G Rao

1

1 reference

4 August 2017

publication date

1 May 2002

1 reference

Rheumatic Diseases Clinics of North America

4 August 2017

published in

1 reference

4 August 2017

volume

28

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

235-259

1 reference

Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Fibromyalgia syndrome a decade later: what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Skeletal muscle abnormalities in patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Fibromyalgia is not a muscle disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Pain mechanisms: a new theory

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Spinal cord pharmacology of pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Central modulation of pain perception

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Neuroanatomy of the pain system and of the pathways that modulate pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Wind-up and the NMDA receptor complex from a clinical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Wind-up of spinal cord neurones and pain sensation: much ado about something?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Evidence for a central component of post-injury pain hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

C fiber responses of wide dynamic range neurons in the spinal dorsal horn.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Lidocaine in the rostroventromedial medulla and the periaqueductal gray attenuates allodynia in neuropathic rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Diffuse noxious inhibitory controls (DNIC). II. Lack of effect on non-convergent neurones, supraspinal involvement and theoretical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Inhibition and facilitation of different nocifensor reflexes by spatially remote noxious stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

NMDA receptor subunits: diversity, development and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurones in the dorsal horn of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

A cure for wind up: NMDA receptor antagonists as potential analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Electrophysiological studies on the effects of intrathecal morphine on nociceptive neurones in the rat dorsal horn.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal, and electrical stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Nitric oxide mediates the thermal hyperalgesia produced in a model of neuropathic pain in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Supraspinal contributions to hyperalgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

The spinal biology in humans and animals of pain states generated by persistent small afferent input

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Cutaneous stimuli releasing immunoreactive substance P in the dorsal horn of the cat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

The tachykinin NK1 receptor. Part I: Ligands and mechanisms of cellular activation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Principles of tachykininergic co-transmission in the peripheral and enteric nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Neurotransmitter functions of mammalian tachykinins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

The tachykinin NK1 receptor in the brain: pharmacology and putative functions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Quantitative autoradiographic distribution of multiple neurokinin binding sites in rat spinal cord.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N - methylamide (SDZ NKT 343), a potent human NK1 tachykinin receptor antagonist with good oral analgesic activity in chronic pain models

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

NK1 (substance P) receptor antagonists--why are they not analgesic in humans?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Combined application of excitatory amino acids and substance P produces long-lasting changes in responses of primate spinothalamic tract neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Enhancement of spinothalamic neuron responses to chemical and mechanical stimuli following combined micro-iontophoretic application of N-methyl-D-aspartic acid and substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Changes in the concentrations of amino acids in the cerebrospinal fluid that correlate with pain in patients with fibromyalgia: implications for nitric oxide pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Cerebrospinal fluid levels of substance P and calcitonin-gene-related peptide: correlation with sural nerve levels and neuropathic signs in sensory diabetic polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Comparison of the effects of substance P, neurokinin A, physalaemin and eledoisin in facilitating a nociceptive reflex in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Hyperalgesia produced by intrathecal substance P and related peptides: desensitization and cross desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Pharmacological evidence for involvement of excitatory amino acids in aversive responses induced by intrathecal substance P in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Transgenic mice over-expressing substance P exhibit allodynia and hyperalgesia which are reversed by substance P and N-methyl-D-aspartate receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Multiple mu opiate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Glycine receptors: what gets in and why?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

The 'ABC' of GABA receptors: a brief review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Pre- and postsynaptic distribution of mu, delta and kappa opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Pharmacology and mechanisms of opioid analgesic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Systemic morphine reduces the wind-up of trigeminal nociceptive neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Functional characteristics of the midbrain periaqueductal gray

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Effects of iontophoresis of noradrenaline and stimulation of the periaqueductal gray on single-unit activity in the rat superficial dorsal horn

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Two forms of inhibition of spinothalamic tract neurons produced by stimulation of the periaqueductal gray and the cerebral cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Organization of tyrosine hydroxylase- and serotonin-immunoreactive brainstem neurons with axon collaterals to the periaqueductal gray and the spinal cord in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Projections from the periaqueductal gray to the rostromedial pericoerulear region and nucleus locus coeruleus: anatomic and physiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Neurotransmitters in Nociceptive Modulatory Circuits

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Dorsal horn projection targets of ON and OFF cells in the rostral ventromedial medulla.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the mu-opioid receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Involvement of 5-hydroxytryptamine-containing neurons in antinociception produced by injection of morphine into nucleus raphe magnus or onto spinal cord.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

GABAA and GABAB receptor site distribution in the rat central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

GABAergic modulation of nociceptive threshold: effects of THIP and bicuculline microinjected in the ventral medulla of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Evidence that disinhibition of brain stem neurones contributes to morphine analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Opioid actions on single nucleus raphe magnus neurons from rat and guinea-pig in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

The effect of modification of 5-hydroxytryptamine function in nucleus raphe magnus on nociceptive threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

A map of serotoninergic structures involved in stimulation producing analgesia in unrestrained freely moving cats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Interactions of descending serotonergic systems with other neurotransmitters in the modulation of nociception

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Glycine and GABAA antagonists reduce the inhibition of primate spinothalamic tract neurons produced by stimulation in periaqueductal gray

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Effects of GABA and glycine receptor antagonists on the activity and PAG-induced inhibition of rat dorsal horn neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

5-HT3 receptor binding sites are on capsaicin-sensitive fibres in the rat spinal cord.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Transmitters involved in antinociception in the spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Descending projections of the locus coeruleus and subcoeruleus/medial parabrachial nuclei in monkey: axonal transport studies and dopamine-beta-hydroxylase immunocytochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Selective reduction by noradrenaline and 5-hydroxytryptamine of nociceptive responses of cat dorsal horn neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Spinal noradrenergic terminal system mediates antinociception

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Antinociceptive effects of intrathecal opioids, noradrenaline and serotonin in rats: mechanical and thermal algesic tests.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Noradrenergic inhibition of the release of substance P from the primary afferents in the rabbit spinal dorsal horn

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

The actions of noradrenaline on neurones of the rat substantia gelatinosa in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Monoaminergic control of the release of calcitonin gene-related peptide- and substance P-like materials from rat spinal cord slices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

alpha-1 and alpha-2 Adrenergic antagonists relieve thermal hyperalgesia in experimental mononeuropathy from chronic constriction injury

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Alpha1-adrenoceptors involvement in painful diabetic neuropathy: a role in allodynia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Morphological study of noradrenaline innervation in the caudal raphe nuclei with special reference to fine structure

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Noradrenergic alpha 1 and alpha 2 receptors: light microscopic autoradiographic localization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Hypoalgesia following microinjection of noradrenergic antagonists in the nucleus raphe magnus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Hypoalgesia induced by microinjection of a norepinephrine antagonist in the raphe magnus: reversal by intrathecal administration of a serotonin antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Evidence for pain modulation by pre- and postsynaptic noradrenergic receptors in the medulla oblongata.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Spinal pathways mediating tonic, coeruleospinal, and raphe-spinal descending inhibition in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Interdependence of spinal adenosinergic, serotonergic and noradrenergic systems mediating antinociception

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Role of glutamate receptors and nitric oxide in the rostral ventromedial medulla in visceral hyperalgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Involvement of excitatory amino acid receptors and nitric oxide in the rostral ventromedial medulla in modulating secondary hyperalgesia produced by mustard oil.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

The glutamate synapse: a target in the pharmacological management of hyperalgesic pain states.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

1 reference

7 January 2021

Management of fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. A double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Cyclobenzaprine: a possible mechanism of action for its muscle relaxant effect

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Cyclobenzaprine, a centrally acting muscle relaxant, acts on descending serotonergic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Amitriptyline, desipramine, cyproheptadine and carbamazepine, in concentrations used therapeutically, reduce kainate- and N-methyl-D-aspartate-induced intracellular Ca2+ levels in neuronal culture

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Imipramine inhibition of transient K+ current: an external open channel blocker preventing fast inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Amitriptyline prevents N-methyl-D-aspartate (NMDA)-induced toxicity, does not prevent NMDA-induced elevations of extracellular glutamate, but augments kainate-induced elevations of glutamate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Block and unblock by imipramine of cloned and mutated P2X2 receptor/channel expressed in Xenopus oocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Differential inhibition of catecholamine secretion by amitriptyline through blockage of nicotinic receptors, sodium channels, and calcium channels in bovine adrenal chromaffin cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Tricyclic antidepressants block NMDA receptor-mediated synaptic responses and induction of long-term potentiation in rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

A randomized controlled trial of citalopram in the treatment of fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

A double-blind placebo controlled trial of fluoxetine in fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Antidepressant treatment of fibromyalgia. A meta-analysis and review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Treatment of fibromyalgia with antidepressants: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Citalopram in patients with fibromyalgia--a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

The efficacy of newer antidepressants in the treatment of chronic pain: a review of current literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Evidence of the dual mechanisms of action of venlafaxine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Neuropharmacology of venlafaxine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

An open clinical trial of venlafaxine treatment of fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Monoamine oxidase inhibitors. An update on drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive offsodes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

The use of mirtazapine in a patient with chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Clinical and Immunomodulatory Effect of Fun-boi, an Herbal Medicine, in Rheumatoid Arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Inhibition of spinal noradrenaline uptake in rats by the centrally acting analgesic tramadol.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Pindolol, a beta-adrenoceptor blocker/5-hydroxytryptamine(1A/1B) antagonist, enhances the analgesic effect of tramadol

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Venlafaxine-tramadol similarities

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Tramadol induces antidepressant-type effects in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

The new generation of GABA enhancers. Potential in the treatment of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Neuropathic pain: aetiology, symptoms, mechanisms, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

3-substituted GABA analogs with central nervous system activity: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Actions of midazolam on GABAergic transmission in substantia gelatinosa neurons of adult rat spinal cord slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Zopiclone in the treatment of sleep abnormalities in fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Comparison of tenoxicam and bromazepan in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

The benzodiazepines as adjuvant analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Anti-spasticity agents for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Imidazoline receptors in cardiovascular and metabolic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

A multicentre placebo-controlled study in general practice to evaluate the efficacy and safety of tizanidine in acute low-back pain

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Do alpha2-adrenoceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Comparison of alpha-adrenoceptor involvement in the antinociceptive action of tizanidine and clonidine in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Antinociceptive activity induced by tizanidine and alpha 2-adrenoreceptors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Baclofen as an adjuvant analgesic

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Baclofen in the treatment of trigeminal neuralgia: double-blind study and long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Efficacy of baclofen in trigeminal neuralgia and some other painful conditions. A clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Ketamine reduces muscle pain, temporal summation, and referred pain in fibromyalgia patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2801%2900004-7

7 January 2021

10.1016/S0889-857X(01)00004-7

Identifiers

DOI

1 reference

4 August 2017

1 reference